CETTA, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 3.824
AS - Asia 2.651
EU - Europa 2.368
SA - Sud America 302
AF - Africa 78
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 9.232
Nazione #
US - Stati Uniti d'America 3.728
CN - Cina 1.401
IE - Irlanda 550
SG - Singapore 544
UA - Ucraina 326
RU - Federazione Russa 277
FI - Finlandia 270
DE - Germania 263
HK - Hong Kong 246
BR - Brasile 220
VN - Vietnam 195
GB - Regno Unito 150
FR - Francia 133
IT - Italia 122
SE - Svezia 105
IN - India 63
CA - Canada 46
ZA - Sudafrica 46
BE - Belgio 37
MX - Messico 37
AR - Argentina 32
TR - Turchia 30
BD - Bangladesh 29
IQ - Iraq 24
PL - Polonia 22
ES - Italia 20
NL - Olanda 20
IR - Iran 18
JP - Giappone 18
CZ - Repubblica Ceca 17
EC - Ecuador 14
CO - Colombia 13
ID - Indonesia 13
PK - Pakistan 13
LT - Lituania 11
AT - Austria 9
MA - Marocco 9
PH - Filippine 8
UZ - Uzbekistan 8
RO - Romania 7
SA - Arabia Saudita 7
AL - Albania 6
MY - Malesia 6
VE - Venezuela 6
CL - Cile 5
DZ - Algeria 5
TW - Taiwan 5
AU - Australia 4
BO - Bolivia 4
ET - Etiopia 4
JM - Giamaica 4
PY - Paraguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DO - Repubblica Dominicana 3
EG - Egitto 3
JO - Giordania 3
KE - Kenya 3
LV - Lettonia 3
NP - Nepal 3
PA - Panama 3
PT - Portogallo 3
TN - Tunisia 3
BG - Bulgaria 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
LB - Libano 2
MD - Moldavia 2
PE - Perù 2
RS - Serbia 2
SN - Senegal 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
HR - Croazia 1
IL - Israele 1
KR - Corea 1
LK - Sri Lanka 1
MK - Macedonia 1
MM - Myanmar 1
MU - Mauritius 1
OM - Oman 1
PR - Porto Rico 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.232
Città #
Dublin 550
Chandler 505
Jacksonville 376
Beijing 326
Ashburn 324
San Jose 321
Singapore 290
Dallas 271
Nanjing 255
Hong Kong 240
Ann Arbor 171
Boardman 144
Nanchang 110
Los Angeles 107
Lawrence 82
Princeton 82
Wilmington 81
Medford 80
Shenyang 80
Changsha 79
Helsinki 75
Munich 71
Hebei 65
Lauterbourg 65
Jiaxing 63
Shanghai 61
Hangzhou 60
Ho Chi Minh City 59
Moscow 55
Woodbridge 55
Tianjin 54
New York 50
Milan 49
Hanoi 46
Buffalo 40
Johannesburg 40
Orem 39
Brussels 36
Turku 33
São Paulo 30
Frankfurt am Main 27
Santa Clara 26
Verona 26
Council Bluffs 25
Houston 24
Auburn Hills 22
Washington 22
Chicago 20
Brooklyn 19
Chennai 19
Warsaw 16
Denver 15
Mexico City 15
Montreal 15
Stockholm 14
The Dalles 14
Tokyo 14
Haiphong 13
London 13
Norwalk 13
Redondo Beach 13
Toronto 13
Atlanta 12
Ankara 11
Seattle 11
Dearborn 10
Falkenstein 10
Kunming 10
Da Nang 9
Pavia 9
Ardabil 8
Boston 8
Brno 8
Des Moines 8
Ningbo 8
Poplar 8
Belo Horizonte 7
Fairfield 7
New Delhi 7
Olomouc 7
Ottawa 7
Phoenix 7
Rio de Janeiro 7
San Francisco 7
Tashkent 7
Amsterdam 6
Baghdad 6
Biên Hòa 6
Casablanca 6
City of London 6
Dhaka 6
Istanbul 6
Jinan 6
Ninh Bình 6
Quito 6
Bogotá 5
Buenos Aires 5
Columbus 5
Curitiba 5
Detroit 5
Totale 6.196
Nome #
A quantitative and qualitative method for direct 2-DE analysis of murine cartilage 179
Adesion proteins in CHO cells. 169
A de novo G to T transversion in a pro-a1(I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain. 165
Biodegradable microspheres for prolidase delivery to human cultured fibroblasts 163
Micellar electrokinetic chromatography for analyzing active site specificity of Pseudomonas aeruginosa elastase. 162
Alpha1-antitrypsin in serum determined by capillary isoelectric focusing 161
Cartilage histogenesis in a murine model of chondrodysplasia 156
Molecular characterisation of six patients with prolidase deficiency: identification of the first small duplication in the prolidase gene and of a mutation generating symptomatic and asymptomatic outcomes within the same family. 151
Effects of lactitol compared to polyethylene glicol-3350 on fecal short chain fatty acids and microflora in old patients with idiopathic chronic constipation. 149
Sequencing prolidase from pig kidney using multiple enzymatic digestion and LC-ESI-QTOF 146
Insights from a transgenic mouse model on the role of SLC26A2 in health and disease. 145
Capillary electrophoresis with laser-induced fluorescence detection as a novel sensitive approach for the analysis of desmosines in real samples. 142
Separation of closely related peptide substrates of human proteinases by micellar electrokinetic chromatography with anionic and nonionic surfactants. 141
In vivo contribution of amino acid sulfur to cartilage proteoglycan sulfation. 139
Investigation on transcellular delivery of active enzyme relased from PLGA microspheres 138
Deficient expression of the small proteoglycan decorin in a case of severe/lethal osteogenesis imperfecta. 137
Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta 135
Mutation analysis of five new patients affected by prolidase deficiency: the lack of enzyme activity causes necrosis-like cell death in cultured fibroblasts 132
A 931 + 2T-->C transition in one COL1A2 allele causes exon 16 skipping in PRO alpha 2(I) mRNA and produces moderately severe OI. 131
Human recombinant prolidase from eukaryotic and prokaryotic sources. Expression, purification, characterization and long-term stability studies. 130
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 130
Direct monitoring of prolidase activity in cultured skin fibroblasts using capillary electrophoresis 128
Deposition of mutant type I collagen in the extracellular matrix of cultured dermal fibroblasts in osteogenesis imperfecta. 127
Characterization of a new PEPD allele causing prolidase deficiency in two unrelated patients: natural-occurrent mutations as a tool to investigate structure-function relationship. 126
Intracellular delivery of liposome-encapsulated prolidase in cultured fibroblasts from prolidase-deficient patients 126
A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype 124
Effect of enamel matrix derivative on human periodontal fibroblasts: proliferation, morphology and root surface colonization. An in vitro study 124
Activity of different proteases in a complex mixture and 'in vitro' study of their reciprocal interferences by micellar electrokinetic chromatography. 123
A base substitution at IVS-19 3'-end splice junction causes exon 20 skipping in pro alpha 2(I) collagen mRNA and produces mild osteogenesis imperfecta. 122
Complete resolution of imidodipeptide mixtures in urine of prolidase-deficient patients using micellar electrokinetic chromatography. 120
Transient beneficial effect of GH replacement therapy and topical GH application on skin ulcers in a boy with prolidase deficiency. 119
Diagnosis of late-infantile neuronal ceroid lipofuscinosis: a new sensitive method to assay lysosomal pepstatin-insensitive proteinase activity in human and animal specimens by capillary electrophoresis. 119
Human prolidase and prolidase deficiency: an overview on the characterization of the enzyme involved in proline recycling and on the effects of its mutations 119
Capillary electrophoresis as a modern tool for determining proteolytic activities in purified specimens and in real samples 119
Optimization of a capillary electrophoretic method to detect and quantify the Gly-Pro dipeptide in complex matrices from long term cultured prolidase deficiency fibroblasts 117
Intracellular release of a liposome-incapsulated biologically active protein 117
Use of capillary zone electrophoresis for analysis of imidodipeptides in urine of prolidase-deficient patients. 117
Anomalous cysteine in type I collagen. Localisation by chemical cleavage of the protein using 2-nitro-5-thiocyanobenzoic acid and by mismatch analysis of cDNA heteroduplexes. 116
Rapid detection of ornithine transcarbamylase activity by micellar electrokinetic chromatography. 115
N-benzyloxycarbonyl-L-proline: an in vitro inhibitor of prolidase. 115
Inhibition of human neutrophil elastase by erythromycin andflurythromycin, two macrolide antibiotics. 114
Enzyme replacement as a new therapy for prolidase deficiency 113
The role of emerging techniques in the investigation of prolidase deficiency: from diagnosis to the development of a possible therapeutical approach 112
Micellar electrokinetic chromatography for the determination of urinary desmosine and isodesmosine in patients affected by chronic obstructive pulmonary disease 110
Effect of the triterpenoid fraction of Centella asiatica on macromolecules of the connective matrix in human skin fibroblast cultures. 110
In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knock-in murine model for classical, dominant osteogenesis imperfecta 110
Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta. 109
Micellar electrokinetic chromatographic and capillary zone electrophoretic methods for screening urinary biomarkers of human disorders: a critical review of the state-of-the-art. 109
Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta. 109
Micellar electrokinetic chromatography as a complementary method to sodium dodecyl sulfate-polyacrylamide gel electrophoresis for studying limited proteolysis of proteins. 109
Severe nonlethal osteogenesis imperfecta: biochemical heterogeneity. 108
Direct monitoring of prolidase activity in cultured skin fibroblasts using capillary electrophoresis. 108
Stability of type I collagen peptide trimers. 106
Micellar electrokinetic chromatography: a convenient alternative to colorimetric and high performance liquid chromatographic detection for monitoring protease activity. 105
Defective proteoglycan sulfation of the growth plate zones causes reduced chondrocyte proliferation via an altered Indian hedgehog signalling 104
High levels of desmosines in urine and plasma of patients with pseudoxanthoma elasticum. 100
Prolidase deficiency in two siblings with chronic leg ulcerations. Clinical, biochemical, and morphologic aspects. 99
Mild, late-onset prolidase deficiency: another Italian case. 96
Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis. 96
Therapeutic apheresis exchange in two patients with prolidase deficiency 95
Type I collagen CNBr peptides: species and behavior in solution 92
Localization of a structural defect in type I procollagen in a patient affected with the severe non-lethal form of Osteogenesis imperfecta. 92
Effect of different surfactants on the separation by micellar electrokinetic chromatography of a complex mixture of dipeptides in urine of prolidase-deficient patients. 91
Evaluation of the TiMo12Zr6Fe2 alloy for orthopaedic implants: in vitro biocompatibility study by using primary human fibroblasts and osteoblasts 90
Severe (type III) osteogenesis imperfecta due to glycine substitutions in the central domain of the collagen triple helix. 90
Osteogenesis imperfecta and type I collagen mutations. A lethal variant caused by a Gly910->Ala substitution in the a1(I) chain. 89
Possible role of overglycosylation in the type I collagen triple helical domain in the molecular pathogenesis of osteogenesis imperfecta. 88
Simultaneous determination of Pseudomonas aeruginosa elastase, human leukocyte elastase and cathepsin G activities by micellar electrokinetic chromatography 86
Diastrophic dysplasia sulfate transporter (DTDST) gene is not involved in pseudodiastrophic dysplasia 85
Paternal mosaicism for a COL1A1 dominant mutation (alpha 1 Ser-415) causes recurrent osteogenesis imperfecta. 85
Undersulfation of proteoglycans synthesized by chondrocytes from a patient with achondrogenesis type 1B homozygous for a Leu483Pro substitution in the diastrophic dysplasia sulfate transporter 84
In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias 82
Proteoglycan modifications in cultured Osteogenesis Imperfecta skin fibroblasts. 78
Gly85 to Val substitution in proa1(I) chain causes mild osteogenesis imperfecta and introduces a susceptibility to protease digestion. 77
Phenotypic comparison of an osteogenesis imperfecta type IV proband with a de novo alpha2(I) Gly922 --> Ser substitution in type I collagen and an unrelated patient with an identical mutation. 77
Serum type I and type III procollagen peptide levels in sarcoidosis. 75
Mild dominant osteogenesis imperfecta with intrafamilial variability: the cause is a serine for glycine a1(I) 901 substitution in a type-I collagen gene. 72
Undersulfation of cartilage proteoglycans ex vivo and increased contribution of amino acid sulfur to sulfation in vitro in McAlister dysplasia/atelosteogenesis type 2 70
Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate production 69
Relationship between changes in alveolar surfactant levels and lung defence mechanisms. 65
Moderately severe osteogenesis imperfecta: biochemical studies showing variable defect localization in the triple-helical domain of type I collagen. 63
Prolidase deficiency: biochemical study of erythrocyte and skin fibroblast prolidase activity in Italian patients. 60
Totale 9.276
Categoria #
all - tutte 35.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.697


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 0 0 0 0 15
2021/2022417 7 12 18 8 10 7 11 29 17 12 67 219
2022/20231.445 129 142 13 113 161 123 5 61 622 20 42 14
2023/2024504 72 90 31 48 51 104 26 29 9 18 17 9
2024/20251.331 40 97 46 34 37 63 69 33 360 39 197 316
2025/20263.024 242 190 372 383 384 176 557 122 286 208 57 47
Totale 9.276